TechCrunch

NOVEMBER 22, 2022

Artificial intelligence has become ubiquitous in clinical diagnosis. “We see ourselves building the foundational layer of artificial intelligence in healthcare. Healthtech startup RedBrick AI has raised $4.6 But researchers need much of their initial time preparing data for training AI systems.

Artificial Inteligence 234

Artificial Inteligence Artificial Intelligence Biotech 3D 234

TechCrunch

SEPTEMBER 13, 2022

French biotech company WhiteLab Genomics has raised $10 million in funding for an AI platform designed to aid the discovery and development of genomic therapies. However, such therapies are typically costly to develop with no guarantee that they’ll work.

Biotech 258

Biotech Development Pharmaceuticals Machine Learning 258

TechCrunch

JUNE 6, 2022

Insilico Medicine, a Hong Kong-based company that has been using artificial intelligence to discover new drugs since 2014, has completed a fresh round of funding. This presents an opportunity for Insilico Medicine to emerge as a winner during the biotech spring.” It has nominated eight preclinical candidates since 2021.

Biotech 211

Biotech Artificial Intelligence Artificial Inteligence Pharmaceuticals 211

Crunchbase News

FEBRUARY 16, 2024

Not exactly sure what was in the water this week, but AI and biotech led the way as happens often. Lambda , $320M, artificial intelligence: In a big week, this was the biggest round. The company offers cloud computing services and hardware for training artificial intelligence software. billion valuation.

Lambda 91

Lambda Biotech Artificial Intelligence Artificial Inteligence 91

Crunchbase News

APRIL 19, 2024

Metsera , $290M, biotech: This week was a slower week than normal for biotech — as it was for most sectors — but that didn’t stop New York-based Metsera. The company develops power-optimized chips targeting the data analytics and generative AI markets. In fact, it only took raising about $30 million-plus to make the list.

Biotech 102

Biotech Generative AI Artificial Intelligence Artificial Inteligence 102

Crunchbase News

MARCH 1, 2024

The quintet that did raise big were from three of the usual sectors — biotech, energy and AI — however one was from a sector we don’t normally see — a vertical farming agtech startup. Fervo Energy, a geothermal developer, locked up a big $244 million round led by shale oil and gas firm Devon Energy Corp.

Energy 92

Energy Biotech Artificial Intelligence Artificial Inteligence 92

TechCrunch

OCTOBER 3, 2022

The software company was developed at Colossal Biosciences — known for its goal to bring extinct critters like the wooly mammoth back to life — and is now striking out on its own. As companies aim to cut costs and reel in spending amid uncertain macroeconomic conditions, Form Bio thinks it is actually the perfect time to launch its platform.

Biotech 240

Biotech Software Machine Learning Artificial Inteligence 240

Crunchbase News

MARCH 29, 2024

While there were no huge rounds like last week, money was again spread around from AI to biotech to marketing and more. Let’s see if April can continue the trend of a growing amount of large raises. This March certainly did not go out like a lamb, with seven rounds hitting $100 million or more in the final week.

Biotech 102

Biotech Artificial Intelligence Artificial Inteligence Energy 102

Crunchbase News

APRIL 5, 2024

Biotech took center stage, notching three of the top four rounds. Obsidian Therapeutics , $161M, biotech: It was another big week for biotech startups raising huge sums of cash. Obsidian is a clinical-stage biotechnology company developing engineered cell and gene therapies.

Biotech 88

Biotech Energy Software Review Systems Review 88

TechCrunch

DECEMBER 2, 2020

Sifting through the trillions of molecules out there that might have powerful medicinal effects is a daunting task, but the solution biotech has found is to work smarter, not harder. Machine learning has, of course, accelerated work in many fields, biochemistry among them, but he felt that the potential of the technology had not been tapped.

Biotech 265

Biotech 3D Artificial Inteligence Machine Learning 265

Crunchbase News

DECEMBER 8, 2023

Rockville, Maryland-based X-energy, a developer of advanced small modular nuclear reactors and fuel technology for clean energy, completed its Series C financing that totaled $235 million. X.AI , $135M, artificial intelligence: You may have heard Elon Musk has an artificial intelligence startup to compete with OpenAI.

Energy 64

Energy Artificial Inteligence Biotech Artificial Intelligence 64

Crunchbase News

MARCH 5, 2024

Figure , $675M, artificial intelligence: Sunnyvale, California-based Figure last week confirmed earlier reports that it had raised a huge $675 million round at a $2.6 The company is developing AI-enhanced robots that it hopes will be able to perform dangerous jobs and alleviate labor shortages. billion, per Crunchbase.

Games 77

Games Artificial Intelligence Artificial Inteligence Biotech 77

Crunchbase News

FEBRUARY 2, 2024

Kore.ai , $150M, artificial intelligence: Another week and another big round for a generative AI startup. The startup is not new to the AI scene — it’s a decade old — and offers an array of artificial intelligence-related tech from virtual assistants to no-code tools to build AI apps. billion, per Crunchbase.

Biotech 76

Biotech Artificial Intelligence Artificial Inteligence Pharmaceuticals 76

Crunchbase News

DECEMBER 21, 2023

Artificial intelligence was big in 2023 — and that could be the understatement of the year. The startup is building what it says will be the “largest AI cluster in the world” and has created large language models to allow people to interact with its AI-powered assistant called Pi, or Personal AI.

Artificial Inteligence 117

Artificial Inteligence Artificial Intelligence Generative AI Biotech 117

Crunchbase News

MARCH 15, 2024

Applied Intuition , $250M, autonomous vehicles: Autonomous vehicle software developer Applied Intuition locked up a $250 million Series E valuing the company at $6 billion — a 67% uptick in value from its previous round. Like many biotech startups raising big money currently, Zephyr is bringing AI to the sector.

Biotech 91

Biotech Artificial Intelligence Artificial Inteligence Cloud 91

TechCrunch

MAY 20, 2022

With cloud-based servers and sophisticated, yet inexpensive, sensors both on the body and off, patients can be monitored at home more effectively than in a hospital, especially when the sensor data is analyzed with artificial intelligence (AI) and machine-learning technology. Opportunities for digital biomarkers.

Artificial Inteligence 231

Artificial Inteligence Artificial Intelligence Healthcare Technical Review 231

TechCrunch

AUGUST 15, 2022

In addition to biotech, Russek felt there also needed to be software and automation components. Finally, artificial intelligence-powered automation and engineering components are designed to remote-monitor the water quality, regulate temperature and oxygenation and feed the shrimp. So they created Atarraya, a U.S.-based

Technology 238

Technology Biotech Artificial Intelligence Artificial Inteligence 238

TechCrunch

APRIL 12, 2022

“Searching for the right solution led the team deep into machine learning techniques, which came with requirements to use large amounts of data and deliver robust models to production consistently … The techniques used were platformized, and the solution was used widely at Lyft.” ” Taking Flyte.

Artificial Inteligence 202

Artificial Inteligence Machine Learning Open Source Biotech 202

TechCrunch

APRIL 19, 2022

. “We use data combined from a large number of previously-run clinical trials. Our product is not an AI model — it’s a clinical trial,” CEO Charles Fisher told TechCrunch via email. “[Our] intention wasn’t to speed clinical trials — it was pure research into machine learning.

Pharmaceuticals 170

Pharmaceuticals Artificial Inteligence Development Machine Learning 170

TechCrunch

AUGUST 10, 2022

Hong Kong-based drug discovery and development company Insilico has secured fresh capital at a time that its CEO described as a “biotech winter.” Insilico uses machine learning to identify potential drug targets and eventually create the drug.

Chemicals 187

Chemicals Biotech Artificial Inteligence Pharmaceuticals 187

TechCrunch

MAY 26, 2021

So a new crop of biotech companies have worked to integrate these aspects. “Next year, we anticipate having our first drug candidate enter the late preclinical phase of development and regulatory work for an IND (investigational new drug) filing with the FDA, and starting the clinical trials in 2023.”

Engineering 248

Engineering Biotech Chemicals Artificial Inteligence 248

Existek

SEPTEMBER 28, 2023

With the major progress in all sub-domains of artificial intelligence, the demand for AI developers has tremendously increased. Moreover, the involvement of AI developers has been proven to play a prominent role in delivering sophisticated products and services. List of the Content What do AI developers do?

Artificial Inteligence 52

Artificial Inteligence Development How To Artificial Intelligence 52

CIO

SEPTEMBER 18, 2023

The latest piece in her reinvention story is Synchrony’s new Tech Apprenticeship for Artificial Intelligence, a full-time, 12-month program that balances on-the-job learning with instructor-led training, providing Chavarin with a pathway into one of the most coveted technology spaces despite her very nontraditional IT background.

Technical Review 340

Technical Review Pharmaceuticals Security Training 340

Crunchbase News

FEBRUARY 7, 2024

Recurrent Energy , $500M, energy: This large round may have gone under the radar for many, but Austin, Texas-based Recurrent Energy secured a $500 million preferred equity investment from BlackRock. Kore.ai , $150M, artificial intelligence: Of course there’s a big round for a generative AI startup. billion in October 2022.

Energy 76

Energy Biotech Artificial Intelligence Artificial Inteligence 76

TechCrunch

JANUARY 25, 2022

The Tunisian startup, headquartered in London with offices in Paris, Tunis, Lagos, Dubai and Cape Town, uses advanced machine learning techniques to bring AI to applications within an enterprise environment. The lab’s mandate was to deploy the latest advances in AI and ML to develop novel immunotherapies.

Enterprise 246

Enterprise Artificial Inteligence Machine Learning Transportation 246

TechCrunch

JANUARY 31, 2022

It’s also a key pillar of Gandeeva, a new biotech company that emerged from stealth on Monday with a $40 million Series A round. The company plans to combine this high-resolution imagery with a suite of machine learning tools to speed up the process of drug discovery. “It Image Credits: Gandeeva Therapeutics.

Artificial Inteligence 231

Artificial Inteligence Machine Learning Biotech Government 231

TechCrunch

SEPTEMBER 8, 2022

Catalog says its current prototype DNA computation and storage platform, or DNA writer, called Shannon, has demonstrated the potential of DNA computation and storage as a proof of concept, but it is a large machine that requires a significant amount of chemistry.

Storage 206

Storage Artificial Inteligence Data Artificial Intelligence 206

Crunchbase News

MARCH 11, 2024

Last month, a16z seemed to have a thing for healthcare and biotech. The firm took part in a $70 million Series B for San Francisco-based Ambience Healthcare , a $170 million Series D for Richmond, California-based BioAge Labs and a huge $254 million round for South San Francisco-based blood-test developer Freenome.

Biotech 89

Biotech Artificial Intelligence Artificial Inteligence Healthcare 89

Crunchbase News

FEBRUARY 15, 2024

Money still coming Investors in the space — which is broad and includes several areas of sectors such as biotech, manufacturing and climate tech — agree that while there has undoubtedly been a slow down in investing, the wide breadth of deep tech and the importance of the problems it is looking to solve has kept money flowing.

Biotech 92

Biotech Artificial Intelligence Artificial Inteligence Energy 92

TechCrunch

NOVEMBER 18, 2021

The drug development space is continuing to attract more and more investment. Generate Biomedicines is touting a platform-based approach to drug development, but with its own spin: a focus on proteins. . Meanwhile, investment in AI-based drug development has also snowballed. Per a Stanford University 2020 report, it reached $13.9

Artificial Inteligence 211

Artificial Inteligence Artificial Intelligence Machine Learning Report 211

Crunchbase News

APRIL 3, 2024

Others include: Imbue , a startup that trains foundational models to develop AI agents, landed $200 million in a September Series B round at a valuation of more than $1 billion. San Francisco-based Replit , a developer platform that uses AI to complete code, has raised $222 million in known funding at a valuation of at least $1.2

Artificial Intelligence 112

Artificial Intelligence Artificial Inteligence CTO Coach Technical Review 112

Crunchbase News

JANUARY 26, 2024

Recurrent Energy , $500M, energy: This large round may have gone under the radar for many, but Austin, Texas-based Recurrent Energy secured a $500 million preferred equity investment from BlackRock. tied) Accent Therapeutics , $75M, biotech: Another week, another big biotech round.

Energy 86

Energy Biotech Pharmaceuticals Fintech 86

TechCrunch

FEBRUARY 14, 2023

million seed round into ModernFi, which is developing a marketplace that helps banks that need deposits to make loans find what they are looking for, while banks with too many deposits can offload them. Letting the AI do your crafting : Writer deploys home-cooked large language models to power up enterprise copy , Devin reports.

Social 249

Social Enterprise Fintech Artificial Inteligence 249

TechCrunch

DECEMBER 15, 2021

Prellis Biologics , a company developing the tools to create 3D-printed organs, announced a $14.5 Prellis has spent years developing tissue engineering capacity, but has focused recently on developing one type of structure in particular. Matheu calls it “natural intelligence” as opposed to artificial intelligence. .

System 203

System Artificial Inteligence 3D Pharmaceuticals 203

Crunchbase News

DECEMBER 20, 2023

Cortical Labs plans to use the money to commercialize its biological computer chips — referred to as DishBrain — which has already learned to play basic video games like Pong. Some think such a development could be the next advancement of AI, since human neurons have some advantages over their digital counterparts.

Biotech 106

Biotech Artificial Intelligence Artificial Inteligence Energy 106

Crunchbase News

JANUARY 8, 2024

In addition to AI, cleantech, biotech and next-generation manufacturing were among the areas where startups scored outsized rounds. For the fourth quarter, the largest early-stage rounds hailed from the biotech space. This past quarter, for instance, Elon Musk ’s artificial intelligence startup xAI picked up $134.7

Biotech 93

Biotech Generative AI Insurance Artificial Intelligence 93

TechCrunch

APRIL 23, 2021

A biotech company that has spent 11 years researching supplements to increase human longevity plans to launch its supplements later this year. PayPal co-founder Peter Thiel invested in Unity Biotechnology , which is developing drugs to treat diseases that accompany aging. And Ethereum founder Vitalik Buterin invested $2.4

Research 261

Research Biotech Nonprofit Comparison 261